4th shot eyed for those immunocompromised | Inquirer News

4th shot eyed for those immunocompromised

/ 05:08 AM February 26, 2022

The Department of Health is coordinating with private firms to train clinic personnel for the administration of COVID-19 vaccines to make immunization accessible to workers.

(FILE PHOTO) Health Usec. Myrna Cabotaje. Screengrab from RTVM

Vaccine experts are studying the possibility of providing a COVID-19 booster shot for immunocompromised individuals, an official of the Department of Health (DOH) said. Considered as immunocompromised persons are those afflicted with the human immunodeficiency virus, cancer or malignancy; transplant recipients; and patients under immunosuppressives. “The primary dose series for immunocompromised consists of three doses—the regular two-dose series, the third dose being an additional dose, and not a booster,” said Health Undersecretary Myrna Cabotaje in an online forum. “A booster, therefore, is being studied, which will be a fourth dose,” she said. Cabotaje also said that the DOH is not yet considering the administration of a second COVID-19 booster shot for other sectors. —Tina G. Santos

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Booster Shot, COVID-19, DoH, vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.